Zimakova I E, Makarchikov N S, Karpov A M
Farmakol Toksikol. 1986 Sep-Oct;49(5):50-3.
Mebicar therapy resulted in a reduction of the degree of deficient disorders of thinking in 27 of 50 patients with paranoid schizophrenia and normalization of indices of mental working capacity, attention and memory, shortening of the time of visual-motor disjunctive reaction in 50 patients with borderline states. Mebicar was shown to possess a nootropic effect which differs qualitatively from that of piracetam.
美比卡治疗使50例偏执型精神分裂症患者中的27例思维缺陷障碍程度减轻，使精神工作能力、注意力和记忆力指标恢复正常，并缩短了50例边缘状态患者视运动分离反应时间。结果表明，美比卡具有与吡拉西坦在性质上不同的促智作用。
